Twenty Years of Turning Research Into Results
  

Call Us Toll Free (877) 397-8980
 

 
 

2011-1 Molecular Infectious Disease Report

The IVD Insights™ Molecular Infectious Disease Market Tracking Report provides a near-census overview of the US molecular infectious disease testing market, covering 31 analytes performed by 1,749 laboratories on 2,928 instrument systems. Laboratory segments include hospitals, independent, public health, blood donor, physician office/outpatient clinics and long-term care/rehabilitation.

 

 

 SITES

 INSTRUMENTS

Short-term Acute Care Hospitals

1,194

1,832

-        University

-        Community Teaching

-        Community Non-teaching

-        Military/VA

-        Critical Access

97

502

500

68

27

369

887

387

183

6
 

Independent Commercial Labs

   318

   794

-        <100K tests per year

-        100K –  249K tests per year

-        250K -  499K tests per year

-        500K – 999K tests per year

-        1M – 4M tests per year

-        4M+ tests per year

19

10

  23

17

45

36

32

23

  34

32

145

214
 

Clinics/POLs

    63

    77

 

 

 

Other

    174

    225

   -        Long-Term Care/Rehab Hospitals

-        Public Health Laboratories

-        Blood Bank Laboratories

110

63

1

141

84

-
 

 

The Report includes information on:

 

System or Method Share

Each manufacturer’s share of systems by model or methods used for testing each analyte
 

Site Penetration  Share

Each manufacturer’s share of sites using each system by model or method for testing each analyte
 

Average Number of Systems per Site

Average number of systems/methods used per site for testing each analyte

 

Total Sites and Installed Base of Systems

Total number of sites in the database and the total instruments in each relevant market segment by manufacturer brand and model in use
 

Share Change of Systems/Methods

Site and analyte share position compared to prior 6 months
 

Volume Share by Analyte

Pilot data available in 2012

 

Volume Share Change by Analyte

Pilot data available in 2012

 

Six Month Volume Change by Analyte

Pilot data available in 2012

 

 

The 33 analytes included in this report include:

 

Molecular Infectious Disease

Adenovirus, qualitative
BK Virus, qualitative
Bordatella parapertussis
Clostridium difficile
Chlamydia/Gonnorrhea
Cytomegalovirus, qualitative
Cytomegalovirus, quantitative
Enterovirus, qualitative
Epstein Barr Virus, qualitative
Epstein Barr Virus, quantitative
Hepatitis B Virus, quantitative
Hepatitis C Virus, qualitative
Hepatitis C Virus, quantitative
Herpes Simplex Virus, qualitative
HHV6, qualitative
HHV8, qualitative
High Risk HPV
HIV Genotyping
HIV, quantitative
Influenza A/B
JC Virus, qualitative
Metapneumovirus, qualitative
MRSA
MSSA
Mycobacterium tuberculosis
Mycoplasma pneumoniae
Norovirus, qualitative
Parainfluenza, qualitative
Respiratory Syncytial Virus, qualitative
Rhinovirus/Enterovirus, qualitative
Varicella Zoster Virus, qualitative

 

 
     
 
Market Diagnostics International, 12001 North Central Expy, Suite 350, Dallas, TX 75243
 A business unit of MDxI, Inc., A multi-faceted market research agency.